Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins

被引:12
作者
Buonamassa, DT
Greer, CE
Capo, S
Yen, TSB
Galeotti, CL
Bensi, G
机构
[1] Chiron SpA, IRIS, Dept Mol Biol, I-53100 Siena, Italy
[2] Chiron Corp, Vaccine Res, Emeryville, CA 94608 USA
[3] Vet Adm Med Ctr, Dept Pathol, San Francisco, CA 94121 USA
[4] Univ Calif San Francisco, San Francisco, CA 94121 USA
关键词
papillomavirus; capsid proteins; VLP assembly; yeast expression;
D O I
10.1006/viro.2001.1289
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The L1 and L2 capsid proteins of animal and human papillomaviruses (HPVs) can self-assemble into virus-like particles (VLPs) that closely resemble native virions. The use of different animal models shows that VLPs can be very efficient at inducing a protective immune response. However, studies with infectious HPV virions and VLPs of different HPV types indicate that the immune response is predominantly type-specific. We have generated a diploid yeast strain that coexpresses the L1 and L2 capsid proteins of both HPV-6b and HPV-16, and we have purified fully assembled VLPs banding in a cesium chloride gradient at the expected density of 1.29-1.3 mg/ml. Experimental evidence strongly indicated that the four proteins coassembled into VLPs. Western blot analysis, using anti-HPV-6 and anti-HPV-16 L1-specific monoclonal antibodies and type-specific L2 antisera, demonstrated that all four proteins copurified, Most importantly, immunoprecipitation experiments, carried out using type-specific anti-L1 monoclonals and either total yeast cell extracts or purified VLPs, confirmed the interaction and the formation of covalent disulfide bonds between the two L1 proteins. Finally, HPV-6/16 VLPs administered to mice induced conformational antibodies against both L1 protein types. These results suggest that coexpression of different capsid proteins may provide new tools for the induction of antibodies directed against multiple HPV types. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:335 / 344
页数:10
相关论文
共 52 条
[1]   Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined immunodeficiency mouse [J].
Bonnez, W ;
Darin, C ;
Borkhuis, C ;
Jensen, KM ;
Reichman, RC ;
Rose, RC .
JOURNAL OF VIROLOGY, 1998, 72 (06) :5256-5261
[2]   PROPAGATION OF HUMAN PAPILLOMAVIRUS TYPE-11 IN HUMAN XENOGRAFTS USING THE SEVERE COMBINED IMMUNODEFICIENCY (SCID) MOUSE AND COMPARISON TO THE NUDE-MOUSE MODEL [J].
BONNEZ, W ;
ROSE, RC ;
DARIN, C ;
BORKHUIS, C ;
JENSEN, KLD ;
REICHMAN, RC .
VIROLOGY, 1993, 197 (01) :455-458
[3]   PHYLOGENETIC ANALYSIS OF 48 PAPILLOMAVIRUS TYPES AND 28 SUBTYPES AND VARIANTS - A SHOWCASE FOR THE MOLECULAR EVOLUTION OF DNA VIRUSES [J].
CHAN, SY ;
BERNARD, HU ;
ONG, CK ;
CHAN, SP ;
HOFMANN, B ;
DELIUS, H .
JOURNAL OF VIROLOGY, 1992, 66 (10) :5714-5725
[4]   ANTIBODY-MEDIATED NEUTRALIZATION INVIVO OF INFECTIOUS PAPILLOMAVIRUSES [J].
CHRISTENSEN, ND ;
KREIDER, JW .
JOURNAL OF VIROLOGY, 1990, 64 (07) :3151-3156
[5]   MONOCLONAL ANTIBODY-MEDIATED NEUTRALIZATION OF INFECTIOUS HUMAN PAPILLOMAVIRUS TYPE-11 [J].
CHRISTENSEN, ND ;
KREIDER, JW ;
CLADEL, NM ;
PATRICK, SD ;
WELSH, PA .
JOURNAL OF VIROLOGY, 1990, 64 (11) :5678-5681
[6]   Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies [J].
Christensen, ND ;
Dillner, J ;
Eklund, C ;
Carter, JJ ;
Wipf, GC ;
Reed, CA ;
Cladel, NM ;
Galloway, DA .
VIROLOGY, 1996, 223 (01) :174-184
[7]   HUMAN PAPILLOMAVIRUS TYPE-6 AND TYPE-11 HAVE ANTIGENICALLY DISTINCT STRONGLY IMMUNOGENIC CONFORMATIONALLY DEPENDENT NEUTRALIZING EPITOPES [J].
CHRISTENSEN, ND ;
KIRNBAUER, R ;
SCHILLER, JT ;
GHIM, SJ ;
SCHLEGEL, R ;
JENSON, AB ;
KREIDER, JW .
VIROLOGY, 1994, 205 (01) :329-335
[8]  
Christie BR, 1996, HIPPOCAMPUS, V6, P1, DOI 10.1002/(SICI)1098-1063(1996)6:1<1::AID-HIPO1>3.0.CO
[9]  
2-U
[10]   IDENTIFICATION OF PROTEINS ENCODED BY THE L1 AND L2 OPEN READING FRAMES OF HUMAN PAPILLOMAVIRUS-1A [J].
DOORBAR, J ;
GALLIMORE, PH .
JOURNAL OF VIROLOGY, 1987, 61 (09) :2793-2799